[NEJM] DOI: 10.1016/S0140-6736(23)02268-7

patrickpth Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-08-27 15:36
Reward10points

Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Senior Member
  • post

  • reply

  • points

    1380


Return to the list